| Emily Theresa Fitzgerald, DPT | |
|
3023 Ny-430, Bemus Point, NY 14712 | |
| (716) 487-5000 | |
| Not Available |
| Full Name | Emily Theresa Fitzgerald |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 3023 Ny-430, Bemus Point, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093245227 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Provider Name | Caring Rehab Pt Pllc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1285334904 PECOS PAC ID: 1850756206 Enrollment ID: O20230508002031 |
News Archive
The U.S. Food and Drug Administration today approved a new indication for Jardiance (empagliflozin) to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and cardiovascular disease.
A major research project from Aarhus University and the Centre for Child and Adolescent Psychiatry, Risskov, in collaboration with the University of Copenhagen, University of Nottingham, UK and Kings College London is published August 1th in the Journal of the American Academy of Child and Adolescent Psychiatry.
Astellas Pharma US, Inc. ("Astellas"), in partnership with the National Science Teachers Association (NSTA), is pleased to welcome its second-year class of Chicago-area science teachers to participate in the 2009 NSTA New Science Teacher Academy.
Patients with advanced non-small cell lung cancer whose disease has progressed following chemotherapy have a higher rate of tumor shrinkage and a longer interval before cancer progression when bevacizumab is added to standard second-line erlotinib therapy, according to a study presented at the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology, sponsored by ASTRO, ASCO, IASLC and the University of Chicago.
Drug cocktails, such as those for treating cancer, are best when the proper ingredients are mixed in the right proportions - just like the alcoholic versions offered at the local bar.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily Theresa Fitzgerald, DPT 682 Pleasant Dr, Warren, PA 16365-3468 Ph: () - | Emily Theresa Fitzgerald, DPT 3023 Ny-430, Bemus Point, NY 14712 Ph: (716) 487-5000 |
News Archive
The U.S. Food and Drug Administration today approved a new indication for Jardiance (empagliflozin) to reduce the risk of cardiovascular death in adult patients with type 2 diabetes mellitus and cardiovascular disease.
A major research project from Aarhus University and the Centre for Child and Adolescent Psychiatry, Risskov, in collaboration with the University of Copenhagen, University of Nottingham, UK and Kings College London is published August 1th in the Journal of the American Academy of Child and Adolescent Psychiatry.
Astellas Pharma US, Inc. ("Astellas"), in partnership with the National Science Teachers Association (NSTA), is pleased to welcome its second-year class of Chicago-area science teachers to participate in the 2009 NSTA New Science Teacher Academy.
Patients with advanced non-small cell lung cancer whose disease has progressed following chemotherapy have a higher rate of tumor shrinkage and a longer interval before cancer progression when bevacizumab is added to standard second-line erlotinib therapy, according to a study presented at the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology, sponsored by ASTRO, ASCO, IASLC and the University of Chicago.
Drug cocktails, such as those for treating cancer, are best when the proper ingredients are mixed in the right proportions - just like the alcoholic versions offered at the local bar.
› Verified 3 days ago